Science News

A vaccine for the most commonly reported sexually transmitted infection in the U.S.—the bacterial disease chlamydia—is now a substantial step closer to reality. On Monday, researchers reported that two of their vaccine candidates were found to be safe in a phase 1 clinical trial of 35 women. Though the trial wasn’t…

Read more…

Read More

Comments

Say Something, or email me at oren@eyalo.com

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Loading Disqus Comments ...

No Trackbacks.